Circulating free testosterone is an independent predictor of advanced disease in patients with clinically localized prostate cancer

Posted on July 4, 2012 by RSS

http://www.medworm.com/index.php?rid=6196824&cid=c_64_47_f&fid=33276&url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa004332u83010p5m%2F

Comments are closed.